S3-2, a novel long-lasting oxyntomodulin derivative, exerts improvement on diabesity and renal injury through activating GLP-1 and glucagon receptors

Huang, P; Meng, LZ; Tan, JH; Gu, XJ; Huang, MY; Huang, FF; Ma, RY; Wang, J

Wang, J (corresponding author), Youjiang Med Univ Nationalities, Affiliated Hosp, Dept Nephrol, Baise 53300, Guangxi, Peoples R China.

LIFE SCIENCES, 2021; 270 ():

Abstract

Aims: To prolong the short lifespan of oxyntomodulin (OXM) for treating obesity and diabetes, we designed a novel fused OXM analog, containing an albu......

Full Text Link